Form D — Bambusa Therapeutics, Inc.
0002044950-25-000002 · filed Jan 8, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $8,999,974
- Reported amount sold
- $8,999,974
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bambusa Therapeutics, Inc.
- CIK
- 2044950
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- ONE MARINA PARK DRIVE, SUITE 1410
BOSTON, Massachusetts 02210 - Phone
- 949-887-7927
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shanshan Xu · Executive OfficerBoston, Massachusetts Find on LinkedIn ↗
-
Helmut Jeggle · DirectorBoston, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗